InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
60,047.90
(
1.36%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

good-pal

Send PM Follow Ignore
Followers 2
Posts 245
Boards Moderated 0
Alias Born 09/09/2005

good-pal

Re: None

Sunday, 09/11/2005 11:07:24 PM

Sunday, September 11, 2005 11:07:24 PM

Post# of 30387
bocx,RECAF,ABT and PSA

PSA projected sales worldwide for 2004 are $450M.

ABT labs own about 1/3 of psa market share (about 150 mil).

RECAF will be used WITH PSA but not as a standalone test
(because PSA has the advantage of localizing the problem to the prostate and RECAF could then determine if the high PSA value is due to a cancer).

the question is when will ABT commercialize recaf and how much bocx will receive in royality ???

any thought??












Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up